Marksans Pharma to acquire QliniQ to expand presence in European pharma markets
Acquisition gives Marksans Pharma direct access to the Netherlands market and strengthens its market access capabilities across…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Marksans Pharma
Marksans Pharma gets US FDA nod for Esomeprazole Magnesium DR Capsules USP, 20 mg (OTC)
Esomeprazole is used to treat certain stomach and esophagus problems such as acid reflux and ulcer
Marksans receives USFDA approval for Guaifenesin ER Tablets (OTC)
Guaifenesin extended-release tablets help to loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways…
Marksans Pharma raises Rs 372.40 crore in equity via conversion of warrants issued to OrbiMed and…
The warrants are converted at a price of Rs 74 per share, reflecting the promoter's and OrbiMed's commitment to the company
Marksans Pharma reports financial results for Q2 and H1FYF23
Operating revenue at Rs 452.6 crore, increased 25.5 per cent YoY, driven by a growth in the existing products as well as market…
World Economic Forum recognises Dr Reddy’s Hyderabad factory as part of its Global Lighthouse…
With this recognition, the facility joins the GLN, a community of over 100 manufacturers that are showing leadership in applying…
Marksans acquires capacity from Tevapharm India
The transaction is in cash consideration, and is expected to be finalised by 1st April, 2023, subject to the usual closing…
Marksans Pharma gets UK MHRA nod for diarrhoea medication
The capsules will be manufactured at the company's Goa-based oral dosage facility
Marksans Pharma and Sun Pharma voluntarily recall metformin
oth the companies are recalling metformin because it may contain N-nitrosodimethylamine (NDMA) above the acceptable intake limit.
Marksans Pharma expands recalls of metformin hydrochloride tablets
It is due to NDMA content in some lots that exceed the acceptable daily intake limit of 96ng/day